These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 6796885)
1. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. Woodcock AA; Gross ER; Gellert A; Shah S; Johnson M; Geddes DM N Engl J Med; 1981 Dec; 305(27):1611-6. PubMed ID: 6796885 [TBL] [Abstract][Full Text] [Related]
2. Dihydrocodeine for breathlessness in "pink puffers". Johnson MA; Woodcock AA; Geddes DM Br Med J (Clin Res Ed); 1983 Feb; 286(6366):675-7. PubMed ID: 6402199 [TBL] [Abstract][Full Text] [Related]
3. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Eimer M; Cable T; Gal P; Rothenberger LA; McCue JD J Fam Pract; 1985 Nov; 21(5):359-62. PubMed ID: 2865326 [TBL] [Abstract][Full Text] [Related]
4. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. Chua TP; Harrington D; Ponikowski P; Webb-Peploe K; Poole-Wilson PA; Coats AJ J Am Coll Cardiol; 1997 Jan; 29(1):147-52. PubMed ID: 8996307 [TBL] [Abstract][Full Text] [Related]
5. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Light RW; Muro JR; Sato RI; Stansbury DW; Fischer CE; Brown SE Am Rev Respir Dis; 1989 Jan; 139(1):126-33. PubMed ID: 2492170 [TBL] [Abstract][Full Text] [Related]
6. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. Eiser N; Denman WT; West C; Luce P Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082 [TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. Murciano D; Auclair MH; Pariente R; Aubier M N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658 [TBL] [Abstract][Full Text] [Related]
8. Surgical therapy for chronic obstructive pulmonary disease. Martinez FJ; Chang A Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435 [TBL] [Abstract][Full Text] [Related]
9. Lung function and exercise performance in hyperthyroidism before and after treatment. Kendrick AH; O'Reilly JF; Laszlo G Q J Med; 1988 Aug; 68(256):615-27. PubMed ID: 3255983 [TBL] [Abstract][Full Text] [Related]
10. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Foglio K; Carone M; Pagani M; Bianchi L; Jones PW; Ambrosino N Respir Med; 2000 Mar; 94(3):256-63. PubMed ID: 10783937 [TBL] [Abstract][Full Text] [Related]
11. [Effect of supplemental oxygen on exercise performance in patients with chronic obstructive pulmonary disease and an arterial oxygen tension over 60 Torr]. Ishimine A; Saito H; Nishimura M; Nakano T; Miyamoto K; Kawakami Y Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):510-9. PubMed ID: 7609336 [TBL] [Abstract][Full Text] [Related]
12. Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease (COPD). Giron AE; Stansbury DW; Fischer CE; Light RW Eur Respir J; 1991 May; 4(5):532-5. PubMed ID: 1936224 [TBL] [Abstract][Full Text] [Related]
13. Effect of aminophylline on exercise performance in patients with irreversible airway obstruction. Vereen LE; Kinasewitz GT; George RB Arch Intern Med; 1986 Jul; 146(7):1349-51. PubMed ID: 3087310 [TBL] [Abstract][Full Text] [Related]
14. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group. Voisin C; Howard P; Ansquer JC Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971 [TBL] [Abstract][Full Text] [Related]
15. Blood volume and arterial blood gases in patients with chronic obstructive lung disease during and after acute respiratory failure. Gertz I Scand J Respir Dis; 1979 Feb; 60(1):6-16. PubMed ID: 441698 [TBL] [Abstract][Full Text] [Related]
16. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. Owens GR; Rogers RM; Pennock BE; Levin D N Engl J Med; 1984 May; 310(19):1218-21. PubMed ID: 6709028 [TBL] [Abstract][Full Text] [Related]
17. Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function. Cabanes L; Costes F; Weber S; Regnard J; Benvenuti C; Castaigne A; Guerin F; Lockhart A N Engl J Med; 1992 Jun; 326(25):1661-5. PubMed ID: 1588979 [TBL] [Abstract][Full Text] [Related]
18. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. Goldstein RS; Ramcharan V; Bowes G; McNicholas WT; Bradley D; Phillipson EA N Engl J Med; 1984 Feb; 310(7):425-9. PubMed ID: 6420700 [TBL] [Abstract][Full Text] [Related]
19. Breathlessness and portable oxygen in chronic obstructive airways disease. Waterhouse JC; Howard P Thorax; 1983 Apr; 38(4):302-6. PubMed ID: 6867984 [TBL] [Abstract][Full Text] [Related]
20. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Mak VH; Bugler JR; Roberts CM; Spiro SG Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]